Zydus Cadila
Zydus Cadila to partner Takeda Pharmaceutical to develop and commercialise vaccine against chikungunya
20 September 2016
Zydus Cadila gets USFDA nod for marketing diabetes drug in US
11 July 2016
Cadila to acquire two drug forms from Teva to strengthen its US portfolio
20 June 2016
Zydus Group initiates Phase III trials of Lipalglyn drug for use in lipodystrophy
30 May 2014
Zydus, Germanyís Pieris tie up to develop `Anticaliní protein drugs
16 October 2013
Zydus US subsidiary to recall one lot of Warfarin blood thinner in US markets
13 June 2013
Zydus Cadila in talks to acquire Strides Arcolab's domestic generic business?
09 May 2012
Zydus Cadila acquires Biochem Pharmaceuticals
21 December 2011
Zydus Cadila arm to acquire US specialty pharma firm Nesher
17 June 2011
Sugar Free Dílite launches TVC
26 August 2010
Cadila gets nod for Phase I trials of novel oral diabetes drug
21 June 2010
India launches indigenous swine flu vaccine
03 June 2010
Cadila's H1N1 vaccine approved for launch in India
13 May 2010
Abbott signs agreement to market 24 Zydus Cadila products
12 May 2010
Zydus Cadilla files application for anti-diabetes drug
04 June 2009
Zydus Cadila, Eli Lily tie up for cardiovascular drug research
30 March 2009
Zydus Cadila acquires Etna Biotech of Italy
11 November 2008
Cadila gets USFDA approval antyi-depressant Risperidone
20 October 2008
Zydus Cadila receives WHO prequalification accreditation for Rabies vaccine
14 October 2008
Zydus Cadila acquires Spanish drug firm Laboratories Combix
30 May 2008
Zydus Cadila to market four products in the US after USFDA approval
16 May 2008
Zydus Cadila launches new drug for cancer therapy
15 February 2008
Zydus Cadila to collaborate with US-based Prolong Pharmaceuticals for drug discovery
24 January 2008
Zydus Cadila gets USFDA nod for anti-rheumatic drug
26 September 2007
Zydus Cadila acquires Brazilian company Nikkho
25 June 2007
Zydus Cadila acquires Nippon Universal of Japan 19 April 2007
19 April 2007
Zydus Cadila acquires Liva Healthcare
17 March 2007
Zydus Cadila files novel drug candidate for obesity disorders
14 November 2006
Zydus Cadila receives US FDA approval to market Warfarin in the US
01 June 2006
Zydus Cadila to commence phase II clinical trials on ZYH1
20 March 2006
Tentative US FDA approval for Zydus Cadila's gatifloxacin tablets
29 November 2005
Zydus Cadila receives approval for Sertraline from AFSSAPS, France
22 November 2005
Zydus Cadila receives tentative US FDA approval for Ribavirin tablets
03 October 2005
German Remedies launches anti Leukaemia drug
09 June 2005
Zydus Cadila commences phase I clinical trials on ZYH1
03 June 2005
Zydus in JV with Australia's Mayne to manufacture oncology products in India
19 May 2005
Zydus ties up Mallinckrodt to market generics in USA
10 March 2005
Zydus Cadila files its first IND application for new molecule
09 February 2005
Zydus Cadila receives US FDA approvals for Clindamycin
01 February 2005
Dr Mahendra Patel joins Zydus Pharmaceuticals
20 January 2005
Zydus Cadila to host second international symposium on genomics and proteomics
14 January 2005
Zydus and Mayne (Australia) sign MoU for JV in India
13 December 2004
Pankaj Patel declared 'best pharma man of the year' by FIIE
01 December 2004
Zydus Cadila reports highest ever sales, net profits up 87 per cent
27 April 2004
Zydus Cadila gears up for the US market
02 April 2004
Zydus Cadila launches Nucoxia
17 March 2004
Zydus Cadila Q2 net rises 30%
20 October 2003
Zydus Cadila becomes a partner of choice for Schering AG
03 October 2003
Zydus Cadila's net profit zooms by 27%
03 May 2003
Zydus Cadila to launch new line of treatment for kala azar
15 March 2003
Zydus Cadila, Berna Biotech tie up to develop cancer vaccines
13 January 2003
Pharma sector fared well in 2001
28 December 2001
Zydus website on healthy lifestyle
15 December 2001
Sildenafil citrate drug sales surge
05 December 2001
Rediscovering Indian pharma market
10 November 2001
Bayer, Zydus end joint venture
21 May 1999
 search domain-b